Respiratory
Inhaled corticosteroids (ICS)
The drugs of choice for long-term control of persistent asthma: they treat the airway inflammation itself, and work only if taken regularly.
Mécanisme d’action
- Corticosteroids inhibit phospholipase A2, reducing the release of arachidonic acid and the inflammatory mediators made from it.
- In the airway they reduce eosinophils, macrophages and T lymphocytes, reverse mucosal oedema, reduce capillary leak and inhibit leukotriene release.
- After several months of regular use, the airways become less hyper-responsive to allergens, irritants, cold air and exercise.
Cibles moléculaires
- Phospholipase A2 (through the glucocorticoid response): Inhibited
Médicaments : Inhaled corticosteroids (ICS)
- Beclometasone
- Budesonide
- Fluticasone
- Mometasone
- Ciclesonide
Indications thérapeutiques
- Regular controller (preventer) therapy for persistent asthma
- Higher doses, or the addition of a long-acting β2 agonist, when control is inadequate
Maladies traitées
Effets indésirables
- Oral thrush (oropharyngeal candidiasis) and hoarseness, from deposition in the mouth and larynx
- Few systemic effects, especially with a spacer; long-term oral steroids carry many
Contre-indications selon le terrain
- Pulmonary tuberculosis (Avec précaution): Corticosteroids suppress the cell-mediated immunity that contains mycobacteria.
- Osteoporosis (Avec précaution): High inhaled doses over years can reduce bone density.
Autres précautions et interactions
- Rinse the mouth with water and spit after each use to reduce thrush and hoarseness; correct inhaler technique is essential.
Sujets liés
Rédigé d’après
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 39, Drugs for Disorders of the Respiratory System, II.D Corticosteroids
Ressource pédagogique. Ne constitue pas un avis, un diagnostic ou un traitement médical.